Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.92 USD | -2.58% | +7.76% | +74.07% |
03-19 | North American Morning Briefing : Stock Futures -2- | DJ |
03-14 | Larimar Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+74.07% | 505M | |
+2.93% | 108B | |
-1.43% | 23.46B | |
-14.60% | 21.72B | |
-7.05% | 18.64B | |
-38.55% | 17.45B | |
-8.83% | 17.19B | |
+5.51% | 13.99B | |
+37.49% | 12.53B | |
+329.39% | 8.81B |
- Stock Market
- Equities
- LRMR Stock
- News Larimar Therapeutics, Inc.
- Citigroup Adjusts Price Target on Larimar Therapeutics to $10 From $4.50, Maintains Buy Rating